LISATA THERAPEUTICS, INC. Repayments of Long-Term Debt
LISATA THERAPEUTICS, INC. (LSTA) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2019-03-14
- LISATA THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2018-12-31 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2018-09-30 was $0.00.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for fiscal 2017 was $5.65M, a 39.55% decline from fiscal 2016.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for fiscal 2016 was $9.35M.
- LISATA THERAPEUTICS, INC. repayments of long-term debt for fiscal 2015 was $0.00.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $0.00 derived: sum of 3 quarters · filed 2019-03-14 | $0.00 10-K · filed 2019-03-14 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | -$354.00 derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | -$354.00 derived: sum of 3 quarters · filed 2019-03-14 | -$354.00 derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 | -$354.00 derived: sum of 2 quarters · filed 2019-03-14 | -$354.00 derived: sum of 3 quarters · filed 2019-03-14 | $4.89M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-12-31 | -$354.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$354.00 derived: sum of 2 quarters · filed 2019-03-14 | $4.89M derived: sum of 3 quarters · filed 2019-03-14 | $5.65M 10-K · filed 2019-03-14 | $5.65M 10-K · filed 2018-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $4.89M derived: sum of 2 quarters · filed 2018-11-08 | $5.65M 10-Q · filed 2018-11-08 | $5.65M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | $4.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $5.65M 10-Q · filed 2018-08-09 | $5.65M derived: sum of 3 quarters · filed 2018-08-09 | $8.65M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | $756.97K 10-Q · filed 2018-05-10 | $756.97K derived: sum of 2 quarters · filed 2018-05-10 | $3.76M derived: sum of 3 quarters · filed 2018-05-10 | $3.76M derived: sum of 4 quarters · filed 2018-05-10 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $3.00M derived: sum of 2 quarters · filed 2018-03-22 | $3.00M derived: sum of 3 quarters · filed 2018-03-22 | $9.35M 10-K · filed 2018-03-22 | |
| 2016-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.00M derived: sum of 2 quarters · filed 2017-11-09 | $9.35M 10-Q · filed 2017-11-09 | $9.35M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $6.35M 10-Q · filed 2017-08-10 | $6.35M derived: sum of 3 quarters · filed 2017-08-10 | $6.35M derived: sum of 4 quarters · filed 2017-08-10 | |
| 2016-03-31 | $6.35M 10-Q · filed 2017-05-15 | $6.35M derived: sum of 2 quarters · filed 2017-05-15 | $6.35M derived: sum of 3 quarters · filed 2017-05-15 | $6.35M derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | $0.00 derived: sum of 2 quarters · filed 2017-03-17 | $0.00 derived: sum of 3 quarters · filed 2017-03-17 | $0.00 10-K · filed 2017-03-17 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $0.00 derived: sum of 2 quarters · filed 2016-11-07 | $0.00 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |